Your browser doesn't support javascript.
loading
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials.
Barbarot, S; Wollenberg, A; Silverberg, J I; Deleuran, M; Pellacani, G; Armario-Hita, J C; Chen, Z; Shumel, B; Eckert, L; Gadkari, A; Lu, Y; Rossi, A B.
Afiliação
  • Barbarot S; Service de Dermatologie, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Wollenberg A; Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.
  • Silverberg JI; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Deleuran M; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Pellacani G; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
  • Armario-Hita JC; Service of Dermatology, University Hospital of Puerto Real, University of Cádiz, Cádiz, Spain.
  • Chen Z; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Shumel B; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Eckert L; Sanofi, Chilly-Mazarin, France.
  • Gadkari A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Lu Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Rossi AB; Sanofi Genzyme, Cambridge, MA, USA.
J Dermatolog Treat ; 33(1): 266-277, 2022 Feb.
Article em En | MEDLINE | ID: mdl-32347763

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: J Dermatolog Treat Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: J Dermatolog Treat Ano de publicação: 2022 Tipo de documento: Article